Starling Oncology, Inc.
- Last sale
- Aug 26, 2026
- Market cap
- —
- no share count on file
- Filings
- 552
Q3 2026+27.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−32.4% FY25 yoy
Price
Aug 26, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $502,729,000 | reported | |
| FY 2024 | 2024-12-31 | $393,412,000 | reported | |
| FY 2023 | 2023-12-31 | $324,239,000 | reported | |
| FY 2022 | 2022-12-31 | $252,483,000 | reported | |
| FY 2021 | 2021-12-31 | $203,003,000 | reported | |
| FY 2020 | 2020-12-31 | $187,515,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $0.00 | $0.00 | — | 75.75M sh | +1.9% | — |
| FY2023 | — | $1.02M | $1.02M | — | 74.31M sh | −0.3% | — |
| FY2022 | — | $9.00M | $9.00M | — | 74.55M sh | +1.8% | — |
| FY2021 | — | $0.00 | $0.00 | — | 73.25M sh | +218.5% | — |
Segments
LineFY2025ShareChange
Specialty pharmacy$269.18M54%+49.6%
Patient services$228.99M46%+11.8%
Clinical trials & other$4.56M0.9%−47.0%
Dispensary———
Total$502.73M
Offices & clinics of doctors of medicine
Starling Oncology, Inc. is the 3rd largest of the 12 covered companies the SEC files under this code, by revenue. SIC 8011
CompanyRevenueGrowthNet marginMarket cap
TDOCTeladoc Health, Inc.$2.5B1.5%7.9%$1.6BHIMSHims & Hers Health, Inc.$2.3B59.0%5.5%$4.6B
STLNWStarling Oncology, Inc. (this company)$502.7M27.8%12.1%$379.9M
LFMDLifeMD, Inc.$194.1M25.3%7.4%$79.8MSBCSBC Medical Group Holdings Inc$173.6M15.5%29.4%$551.3MAIRSAirsculpt Technologies, Inc.$151.8M15.8%7.7%$53.2MCCMConcord Medical Services Holdings Ltd$65.9M28.3%20.2%$15.5MCDIXCardiff Lexington Corp$11.5M39.5%47.7%$51.5MHLYKHealthLynked Corp$2.1M31.3%158.8%$7.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Starling Oncology, Inc. · CIK 1799191 · Engraved from SEC EDGAR